1. Home
  2. CYBN vs MRBK Comparison

CYBN vs MRBK Comparison

Compare CYBN & MRBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYBN
  • MRBK
  • Stock Information
  • Founded
  • CYBN 2019
  • MRBK 2004
  • Country
  • CYBN Canada
  • MRBK United States
  • Employees
  • CYBN N/A
  • MRBK N/A
  • Industry
  • CYBN Pharmaceuticals and Biotechnology
  • MRBK Major Banks
  • Sector
  • CYBN Health Care
  • MRBK Finance
  • Exchange
  • CYBN Nasdaq
  • MRBK Nasdaq
  • Market Cap
  • CYBN 176.5M
  • MRBK 177.5M
  • IPO Year
  • CYBN N/A
  • MRBK 2017
  • Fundamental
  • Price
  • CYBN $6.08
  • MRBK $15.16
  • Analyst Decision
  • CYBN Strong Buy
  • MRBK Buy
  • Analyst Count
  • CYBN 3
  • MRBK 2
  • Target Price
  • CYBN $85.00
  • MRBK $17.50
  • AVG Volume (30 Days)
  • CYBN 621.7K
  • MRBK 64.7K
  • Earning Date
  • CYBN 11-12-2025
  • MRBK 10-23-2025
  • Dividend Yield
  • CYBN N/A
  • MRBK 3.29%
  • EPS Growth
  • CYBN N/A
  • MRBK 69.83
  • EPS
  • CYBN N/A
  • MRBK 1.61
  • Revenue
  • CYBN N/A
  • MRBK $106,330,000.00
  • Revenue This Year
  • CYBN N/A
  • MRBK $25.14
  • Revenue Next Year
  • CYBN N/A
  • MRBK $8.08
  • P/E Ratio
  • CYBN N/A
  • MRBK $9.46
  • Revenue Growth
  • CYBN N/A
  • MRBK 17.11
  • 52 Week Low
  • CYBN $4.81
  • MRBK $10.89
  • 52 Week High
  • CYBN $13.88
  • MRBK $17.33
  • Technical
  • Relative Strength Index (RSI)
  • CYBN 38.92
  • MRBK 48.05
  • Support Level
  • CYBN $6.16
  • MRBK $15.35
  • Resistance Level
  • CYBN $6.55
  • MRBK $15.71
  • Average True Range (ATR)
  • CYBN 0.49
  • MRBK 0.20
  • MACD
  • CYBN -0.06
  • MRBK -0.08
  • Stochastic Oscillator
  • CYBN 12.90
  • MRBK 4.51

About CYBN Cybin Inc.

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.

About MRBK Meridian Corporation

Meridian Corp is a bank holding company. Through its banking subsidiary, it operates as a full-service, state-chartered commercial bank providing personal, business lending, and deposit services. It operates in three reportable segments including Bank, Wealth, and Mortgage. The company generates maximum revenue from the Bank segment which consists of commercial and retail banking. It generates interest income from its lending (including leasing) and investing activities and is dependent on the gathering of lower-cost deposits from its branch network or borrowed funds from other sources for funding its loans.

Share on Social Networks: